Publications
- Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?2023 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine, Third Faculty of Medicine
- Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study2022 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Cellular and humoral immune responses to SARS-CoV-2 vaccination in inflammatory bowel disease patients2022 | First Faculty of Medicine, Second Faculty of Medicine
- Porcine Model of Anastomotic Stricture in Crohn's Disease2022 | Third Faculty of Medicine
- Neobvyklý typ překryvného syndromu u pacientky s Crohnovou chorobou2021 | First Faculty of Medicine
- Obesity and kidney2017 | First Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University
- Biosimilar infliximab in anti-TNF-naïve IBD patients - 1-year clinical follow-up2016 | First Faculty of Medicine
Loading network view...
